Breast Cancer Awareness Month 2026.

The 2026 theme, “Every Story Is Unique, Every Journey Matters,” highlights the individual experiences of people affected by breast cancer. Screening needs and treatment options can vary from person to person, making it important to understand your risk and explore your options.

This guide covers current screening recommendations, breast cancer risk factors, and clinical research opportunities in Oklahoma City.

When Is Breast Cancer Awareness Month?

It takes place every October. Its message is familiar: understand breast cancer risk, encourage appropriate screening, and seek medical advice when needed. Awareness matters most when it helps people make informed decisions about their health.

On October 1, 2026, the American Cancer Society published findings from a survey of approximately 33,000 US women. The results highlighted a gap between awareness of modifiable breast cancer risk factors and preventive habits. Although 91% recognized the link between low physical activity and breast cancer risk, only 27% met ACS activity recommendations. Nearly 45% did not know that breastfeeding is associated with a lower risk.

That gap has plenty of reasons. Work, caregiving, access to healthcare, and cost can all push preventive care down the list. Breast Cancer Awareness Month can serve as a reminder to understand your risk and discuss concerns with a healthcare professional.

How Common Is Breast Cancer in 2026?

Breast cancer accounts for about 15% of all new cancer cases in the US. The breast cancer projections for 2026 are below.

When Should You Start Breast Cancer Screening?

The recommended age to start breast cancer screening depends on which medical organization’s guidance you follow and your personal risk. In April 2026, the American College of Physicians (ACP) issued updated guidance recommending mammograms every two years for average-risk women ages 50 to 74.

For average-risk women ages 40 to 49, the ACP recommends discussing individual risk with a healthcare professional. If a woman in this age group prefers screening after shared decision-making, the ACP recommends starting mammograms every two years.

Other organizations recommend earlier or more frequent screening. The US Preventive Services Task Force recommends mammograms every two years for women ages 40 to 74. The American College of Radiology recommends annual screening beginning at age 40 for women at average risk.

What If You Have Dense Breasts?

Dense breast tissue can make mammograms harder to interpret because both dense tissue and tumors can appear white on the image. They can also reduce mammography’s ability to detect cancer.

That does not automatically mean you need additional imaging. The USPSTF states that evidence is insufficient to recommend for or against supplemental ultrasound or MRI after a normal mammogram in women with dense breasts. Additional imaging may detect cancers that mammography misses, but the overall balance of benefits and harms remains uncertain.

How Do Breast Cancer Risk Factors Shape Your Plan?

A breast cancer risk assessment can help you understand which factors may affect your chances of developing the disease. Your healthcare professional may consider factors such as:

• Family history and genetics: Close relatives with breast cancer and certain inherited gene changes can increase risk.
• Lifestyle: Alcohol consumption, physical inactivity, and excess body weight after menopause can affect risk.
• Reproductive history: Factors such as age at first menstruation, age at menopause, and having a first full-term pregnancy later in life can influence risk.
• Breastfeeding: Breastfeeding is associated with a lower risk of breast cancer.

Family history can increase your risk, but 85% of women diagnosed with breast cancer have no known family history.

The American Cancer Society’s CancerRisk360 assessment can help you identify factors you may be able to change and suggest practical steps to reduce your overall cancer risk. It does not, however, replace a clinical assessment or provide a numerical estimate of your personal breast cancer risk.

Why Do Clinical Trials Matter in Breast Cancer Care?

Many of the treatments used in breast cancer care were studied in clinical trials before they became available to patients. Breast Cancer Clinical Trials may investigate new drug combinations, new uses for existing medicines, or treatments matched to specific tumor biomarkers. Some studies examine ways to reduce recurrence risk or improve outcomes after surgery.

A clinical trial is not necessarily a last resort. Depending on the study, you may be able to participate at different points in your treatment. Eligibility varies by study. Research teams may review:

• Cancer subtype and stage.
• Previous treatments and surgery.
• Pathology and laboratory results.
• Age and overall health.

Participation is voluntary. You can ask questions about the study, its potential benefits and risks, and what participation involves before deciding.

What Breast Cancer Research Is Happening in Oklahoma City?

Hightower Clinical is a Clinical Research Organization in Oklahoma City with experience conducting more than 500 Phase I to IV clinical trials. For eligible patients, a local research site may reduce the travel required for study visits.

Our clinical research studies in oncology include research involving triple-negative breast cancer (TNBC). These tumors test negative for estrogen receptors, progesterone receptors, and HER2, which limits the use of treatments that target those markers. Our study is evaluating an investigational targeted therapy combined with immunotherapy against treatment selected by the study physician.

Eligible participants receive study-related procedures and treatment at no cost. Insurance is also not required.

If you are interested in breast cancer trials in Oklahoma City, you can submit the contact form. A member of the research team can then contact you to discuss the study and assess your initial eligibility.

What Should You Ask Your Doctor About Breast Cancer Research?

If you are considering a clinical trial, prepare a few questions for your next appointment. You could ask:

• Could my breast cancer subtype make me eligible for a clinical trial?
• Would joining a trial change my current treatment plan?
• What are the potential benefits, risks, and side effects?
• How often would I need to attend study visits?
• What standard treatment options are available if I decide not to join the trial?

The Takeaway

Use Breast Cancer Awareness Month as a prompt to take one practical step. Discuss your personal risk with a healthcare professional or ask your oncology team whether a clinical trial may be appropriate.

And if you are exploring research options in Oklahoma City, the Hightower Clinical team can explain the available study and help you understand the initial eligibility requirements.